Strategic Blueprint’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
VCM
VPM
Strategic Blueprint's IDXX Position: Q1 2026 in Review
Strategic Blueprint reduced its Idexx Laboratories (IDXX) stake by 1.3% in Q1 2026, selling an estimated $3.85K and leaving 455 shares worth $256K. The position accounts for 0.01% of the portfolio, ranked #559.
Strategic Blueprint first reported a position in IDXX in Q3 2019 and has held it in 20 quarters since. The position peaked at $412K in Q4 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Strategic Blueprint held 455 shares of Idexx Laboratories worth $256K as of Q1 2026.
- Strategic Blueprint sold 6 Idexx Laboratories shares in Q1 2026, an estimated $3.85K.
- Idexx Laboratories made up 0.01% of Strategic Blueprint's portfolio in Q1 2026, its #559 holding.
- Strategic Blueprint first reported a position in Idexx Laboratories in Q3 2019 and has held it in 20 quarters since.
- Strategic Blueprint's Idexx Laboratories position peaked at $412K in Q4 2021.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Strategic Blueprint's 13F filing for Q1 2026, filed 29 Apr 2026.